Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells $247,400.00 in Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $123.70, for a total value of $247,400.00. Following the completion of the sale, the director now directly owns 52,825 shares of the company’s stock, valued at $6,534,452.50. This trade represents a 3.65 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Huron Consulting Group Stock Up 0.3 %

HURN opened at $123.11 on Monday. Huron Consulting Group Inc. has a fifty-two week low of $84.26 and a fifty-two week high of $131.06. The company’s 50-day moving average is $115.63 and its 200 day moving average is $107.09. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market capitalization of $2.18 billion, a P/E ratio of 26.76 and a beta of 0.60.

Huron Consulting Group (NASDAQ:HURN) last released its earnings results on Tuesday, October 29th. The business services provider reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.11. The company had revenue of $370.00 million for the quarter, compared to analysts’ expectations of $377.63 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.39 EPS. Research analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HURN. StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Benchmark reissued a “buy” rating and set a $140.00 target price on shares of Huron Consulting Group in a research report on Wednesday, October 30th. Finally, Barrington Research raised their price target on shares of Huron Consulting Group from $137.00 to $142.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $133.00.

Institutional Trading of Huron Consulting Group

Several hedge funds have recently made changes to their positions in the company. Simplicity Wealth LLC purchased a new position in Huron Consulting Group in the 2nd quarter valued at approximately $584,000. Quest Partners LLC grew its position in shares of Huron Consulting Group by 131.9% in the third quarter. Quest Partners LLC now owns 13,814 shares of the business services provider’s stock valued at $1,502,000 after purchasing an additional 7,858 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Huron Consulting Group by 435.2% during the 2nd quarter. Victory Capital Management Inc. now owns 64,674 shares of the business services provider’s stock valued at $6,370,000 after purchasing an additional 52,589 shares during the period. Natixis Advisors LLC lifted its holdings in Huron Consulting Group by 32.7% during the 3rd quarter. Natixis Advisors LLC now owns 18,571 shares of the business services provider’s stock worth $2,019,000 after purchasing an additional 4,576 shares in the last quarter. Finally, Atom Investors LP bought a new position in Huron Consulting Group in the 3rd quarter worth about $1,159,000. 93.90% of the stock is currently owned by institutional investors.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.